Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine.

Source:http://linkedlifedata.com/resource/pubmed/id/11821898

Download in:

View as

General Info

PMID
11821898